Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10533001 Inhibitors of protein kinases

Patent 10533001 was granted and assigned to Portola Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Portola Pharmaceuticals

Current Assignee

Portola Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10533001

Date of Patent

January 14, 2020

Patent Application Number

15828154

Date Filed

November 30, 2017

Patent Citations Received

‌

US Patent 11339145 Synthesis of cerdulatinib

‌

US Patent 10865198 Solid forms of cerdulatinib

‌

US Patent 11661414 Solid forms of Cerdulatinib

‌

US Patent 11713309 Solid forms of Cerdulatinib

‌

US Patent 10851087 Synthesis of cerdulatinib

Patent Primary Examiner

‌

Marcos L Sznaidman

Patent abstract

The present invention is directed to topical pharmaceutical compositions of Formula (If)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10533001 Inhibitors of protein kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API